Heyuan N. is a co-founder of Utero Diagnostics, where efforts focus on developing an in vitro diagnostic product using CRISPR for at-home endometriosis diagnosis, with ambitions to broaden the technology's applications in female and reproductive health. Currently enrolled at the University of California, Berkeley, Heyuan N. holds multiple research roles, including undergraduate researcher at the Stanley Lab and the Landry Lab, as well as data science research. Additional leadership positions include roles as co-founder of the US-China Life Sciences Venture Club and executive board member of iGEM at Berkeley. Heyuan N. is pursuing a Bachelor of Arts in Molecular and Cell Biology (Honors), a Bachelor of Science in Business Administration, and a Bachelor of Arts in Data Science, along with completion of the Harvard Secondary School Program and relevant high school education in both China and the United States.